This episode of Business Daily begins with a real call to 911There's an antidote for an opioid overdose. It costs a few dollars. The nasal spray technology means it can be administered without needles and can restart a person's breathing within minutes. So why doesn't it always reach the person on the floor? We're following the money through the antidote economy. A life-saving drug that costs pennies to make. Sold over the counter for $52. But when drug companies were sued for their role in America's opioid crisis, some pharmaceutical companies' settlements included paying out using antidote kits valued at $125. Who profits, who pays, and what determines whether an overdose kit is ever in the room when it's needed?Presenter: Sam Fenwick
Producers: Josh Martin and Matt LinesYou can email the team: <a href="mailto:businessdaily@bbc.co.uk">businessdaily@bbc.co.uk</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Follow the Money: The antidote economy

Business Daily

AI Chapters

AI Insights

Reviews